Transcobalamin 776C-→G polymorphism negatively affects vitamin B-12 metabolism

American Journal of Clinical Nutrition

Volumn 81, Issue 6, 2005, Pages 1436-1441

  Von Castel Dunwoody, Kristina M ^a   Kauwell, Gail P A ^a   Shelnutt, Karla P ^a   Vaughn, Jaimie D ^a   Griffin, Elizabeth R ^a   Maneval, David R ^a   Theriaque, Douglas W ^b   Bailey, Lynn B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Holotranscobalamin; HomocysteinE; Polymorphisms; Transcobalamin; Vitamin B 12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; HOMOCYSTEINE; TRANSCOBALAMIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; NUTRITIONAL STATUS; VITAMIN METABOLISM; BLOOD; DIET; DIET SUPPLEMENTATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; METHODOLOGY; POLYMERASE CHAIN REACTION;

ADULT; DIET; DIETARY SUPPLEMENTS; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TRANSCOBALAMINS; VITAMIN B 12;

EID: 21944449648     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/81.6.1436     Document Type: Article

References (53)

1. Stabler SP. Vitamin B12. In: Bowman BA, Russell RM, eds. Present knowledge in nutrition. Washington, DC: ILSI Press, 2001:230-40.
2. Bautista LE, Arenas IA, Penuela A, Martinez LX. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol 2002;55:882-7.
3. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149-51.
4. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-22.
5. Vollset SE, Refsum H, Irgens LM, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000;71:962-8.
6. Vollset SE, Refsum H, Tverdal A, et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 2001;74:130-6.
7. Refsum H. Folate, vitamin B12 and homocysteine in relation to birth defects and pregnancy outcome. Br J Nutr 2001;85:S109-13.
8. Carmel R. The distribution of endogenous cobalamin among cobalaminbinding proteins in the blood in normal and abnormal states. Am J Clin Nutr 1985:41:713-9.
9. Hall CA. The carriers of native vitamin B12 in normal human serum. Clin Sci Mol Med 1977;53:453-7.
10. Carmel R. Cobalamin deficency. In: Carmel R, Jacobson DW, eds. Homocysteine in health and disease. New York: Cambridge University Press, 2001:289-305.
11. Namour F, Guy M, Aimone-Gastin I, de Nonancourt M, Mrabet N, Gueant J-L. Isoelectrofocusing phenotype and relative concentration of transcobalamin II. Isoproteins related to the codon 259 Arg/Pro polymorphism. Biochem Biophys Res Commun 1998;251:769-74.
12. Afman LA, Van Der Put NMJ, Thomas CMG, Trijbels JMF, Blom HJ. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. QJM 2001;94:159-66.
13. McCaddon A, Blennow K, Hudson P, et al. Transcobalamin polymorphism and homocysteine. Blood 2001;98:3497-500.
14. Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R. Transcobalamin II 775G>C polymorphism and indices of vitamin B12 status in healthy older adults. Blood 2002;100:718-20.
15. Afman LA, Lievers KJ, van der Put NM, Trijbels FJ, Blom HJ. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 2002;10:433-8.
16. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22:195-201.
17. Mann NJ, Li D, Sinclair AJ, et al. The effect of diet on plasma homocysteine concentrations in healthy male subjects. Eur J Clin Nutr 1999; 53:895-9.
18. Mezzano D, Kosiel K, Martinez C, et al. Cardiovascular risk factors in vegetarians: normalization of hyperhomocysteinemia with vitamin B12 and reduction of platelet aggregation with n-3 fatty acids. Thromb Res 2000;100:153-60.
19. Shelnutt KP, Kauwell GPA, Chapman CM, et al. Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase C677T polymorphism in young women. J Nutr 2003:113: 4107-11.
20. Ulleland M, Eilertsen I, Quadros EV, et al. Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum. Clin Chem 2002;48:526-32.
21. Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 1999;45:290-2.
22. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
23. Bailey LB, Duhaney RL, Maneval DR, et al. Vitamin B-12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms. J Nutr 2002;132:1872-8.
24. Prince JA, Feuk L, Howell WM, et al. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 2001; 11:152-62.
25. Lindgren A, Kilander A, Bagge E, Nexo E. Holo-transcobalamin-a sensitive marker of cobalamin malabsorption. Eur J Clin Invest 1999; 29:321-9.
26. Lindenbaum J, Allen R. Clinical spectrum and diagnosis of folate deficiency. In: Bailey L, ed. Folate in health and disease. New York: Marcel Decker, 1995:43-73.
27. Institute of Medicine. Vitamin B12. Dietary reference intakes. Washington, DC: National Academy Press, 1998:306-56.
28. Institute of Medicine. Folate. Dietary reference intakes. Washington, DC: National Academy Press, 1998:196-305.
29. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998;98:2520-6.
30. Vaughn JD, Bailey LB, Shelnutt KP, et al. Methionine synthase reductase 66A→G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C→T variant. J Nutr 2004;134:2985-90.
31. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-23.
32. van der Put N, Thomas C, Eskes T, et al. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 1997;90:505-10.
33. Magnus P, Magnus EM, Berg K. Transcobalamins in the etiology of neural tube defects. Clin Genet 1991:39:309-10.
34. Wright ME. A case-control study of maternal nutrition and neural tube defects in Northern Ireland. Midwifery 1995;11:146-52.
35. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993;86:703-8.
36. Bird AP, Wolffe AP. Methylation-induced repression-belts, braces, and chromatin. Cell 1999;99:451-4.
37. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001;293:1068-70.
38. Steegers-Theunissen RP, Boers GH, Blom HJ, et al. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 1995;172:1436-41.
39. Eskes TK. Homocysteine and human reproduction. Clin Exp Obstet Gynecol 2000;27:157-67.
40. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990;34:90-8.
41. Bailey LB, Moyers S, Gregory JF. Folate. In: Bowman BA, Russell RM, eds. Present knowledge in nutrition. Washington, DC: ILSI Press, 2001 : 214-29.
42. Obeid R, Jouma M, Herrmann W. Cobalamin status (holo-transcobalamin, methylmalonic acid) and folate as determinants of homocysteine concentration. Clin Chem 2002;48:2064-5.
43. Carmel R. Measuring and interpreting holo-transcobalamin (holo-transcobalamin II). Clin Chem 2002;48:407-9.
44. Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr 1994;59(suppl):1213S-22S.
45. Nexo E, Hvas A-M, Bleie O, et al. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem 2002;48:1768-71.
46. Herrmann W, Schorr H, Obeid R, Geisel J. Vitamin B-12 status, particularly holo-transcobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr 2003;78: 131-6.
47. Herzlich B, Herbert V. Depletion of serum holo-transcobalamin II. An early sign of negative vitamin B12 balance. Lab Invest 1988;58:332-7.
48. Lloyd-Wright Z, Hvas A-M, Moller J, Sanders TAB, Nexo E. Holo-transcobalamin as an indicator of dietary vitamin B12 deficiency. Clin Chem 2003;49:2076-8.
49. Obeid R, Geisel J, Schorr H, Hubner U, Herrmann W. The impact of vegetarianism on some haematological parameters. Eur J Haematol 2002;69:275-9.
50. Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 2002;6:39-42.
51. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
52. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-7.
53. Gueant-Rodriguez RM, Rendeli C, Namour B, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003;344:189-92.